Oruka Therapeutics COO Sandler sells $167,821 in shares
Biogen at TD Cowen Conference: Strategic Expansion and Challenges
Ouster Q4 2025 slides: revenue doubles, margins expand to 60%
Dave Q4 2025 slides: revenue surges 62%, EBITDA margin hits 45%
Earnings call transcript: Asana Q4 2026 earnings beat estimates, stock fluctuates
Newsletter
Subscribe to get the latest news, offers and special announcements.


